Medical note: This article is for educational purposes only and does not replace care from a licensed healthcare professional. Migraine treatment should be personalized, especially if you are pregnant, have heart disease, have uncontrolled high blood pressure, take other migraine medicines, or experience new or worsening neurological symptoms.
Migraine is not “just a headache,” the same way a thunderstorm is not “just a little weather.” A migraine attack can bring throbbing pain, nausea, vomiting, light sensitivity, sound sensitivity, neck stiffness, dizziness, aura, brain fog, and the sincere desire to live inside a quiet cave with excellent blackout curtains. For many people, tablets work well enough. For others, swallowing a pill during nausea is about as appealing as eating soup on a roller coaster.
That is where injectable migraine treatments come in. Some are designed to prevent attacks before they start. Others are rescue treatments used when an attack is already underway. The biggest names include CGRP monoclonal antibody injections, intravenous CGRP infusions, Botox injections for chronic migraine, sumatriptan injections, dihydroergotamine injections, and certain nerve-block procedures performed by headache specialists.
These treatments are not magic wands, although anyone who has lost whole weekends to migraine would happily accept one. Instead, they work by targeting specific migraine pathways: calming overactive pain signaling, blocking migraine-related proteins, relaxing sensitized nerves, or stopping an attack from escalating. The goal is simple: fewer migraine days, less intense symptoms, better function, and fewer emergency “please turn off the sun” moments.
What are injectable migraine treatments?
Injectable treatments for migraine are medications or procedures delivered under the skin, into a muscle, into a vein, or around irritated nerves. They may be given at home with an autoinjector, in a doctor’s office, at an infusion center, or in urgent care. The right option depends on whether the goal is prevention or fast relief.
Preventive injectable treatments
Preventive injections are used on a schedule, even when you are not currently having a migraine attack. They are most often considered when migraine attacks are frequent, disabling, difficult to treat with oral medication, or linked with medication overuse. Preventive injectables include CGRP monoclonal antibodies and Botox for chronic migraine.
Acute or rescue injectable treatments
Acute injections are used after a migraine attack begins. They are helpful when symptoms rise quickly, nausea prevents oral medication, or previous tablets have not worked reliably. Common examples include sumatriptan injection and dihydroergotamine, often called DHE. These treatments are not meant to be used casually or too often, because overuse of acute migraine medication can worsen headache patterns over time.
How migraine injections work in the body
Migraine involves abnormal communication between the brain, blood vessels, trigeminal nerves, and inflammatory signaling molecules. One of the most important molecules is calcitonin gene-related peptide, better known as CGRP. During migraine attacks, CGRP can increase pain signaling and contribute to inflammation around nerves. Think of it as a tiny biochemical hype man shouting, “Let’s make this worse!”
CGRP-targeting treatments reduce this effect by blocking either CGRP itself or the receptor it attaches to. Botox works differently. It is injected into specific head and neck areas and appears to reduce the release of pain-related chemicals from nerve endings. Sumatriptan and DHE are used acutely and affect serotonin-related pathways that help quiet migraine signaling once an attack has started.
The important point is that migraine injections are not one single category. They are a toolbox. Some tools are for prevention, some are for rescue, and some are for special situations such as chronic migraine, severe nausea, or attacks that last for days.
CGRP monoclonal antibody injections
CGRP monoclonal antibodies are among the most migraine-specific preventive treatments available. Unlike older preventive medicines that were originally developed for blood pressure, seizures, or depression, CGRP therapies were designed with migraine biology in mind. That does not make them perfect, but it does make them refreshingly direct.
The main injectable or infusion CGRP monoclonal antibodies used for migraine prevention include erenumab, fremanezumab, galcanezumab, and eptinezumab. Erenumab targets the CGRP receptor. Fremanezumab, galcanezumab, and eptinezumab target the CGRP molecule itself. The end result is similar: less CGRP activity, fewer migraine attacks for many patients, and a treatment schedule that is often easier than taking a daily pill.
Common CGRP injection options
Erenumab is usually injected under the skin once a month. It is commonly given with an autoinjector or prefilled syringe. Some patients use a lower monthly dose, while others may be prescribed a higher monthly dose depending on response and tolerability.
Fremanezumab can be injected monthly or quarterly, depending on the prescribed schedule. The quarterly option may involve multiple injections on the same day, which is not everyone’s idea of a party, but it can be convenient for people who prefer fewer treatment days per year.
Galcanezumab is typically started with a loading dose followed by monthly injections. The loading dose helps the medicine reach an effective level more quickly.
Eptinezumab is given by intravenous infusion, usually every three months. Because it goes directly into a vein, it is administered in a healthcare setting rather than at home. This may appeal to people who dislike self-injection or who prefer supervised treatment.
Benefits of CGRP migraine injections
For many patients, CGRP injections can reduce the number of monthly migraine days, decrease attack severity, improve response to acute medication, and make life feel less like a calendar full of cancellations. They may be especially attractive for people who did not tolerate older preventive drugs because of fatigue, weight changes, mood effects, brain fog, or blood pressure issues.
Another advantage is convenience. Monthly or quarterly dosing can be easier to follow than a daily pill, particularly for people who already take several medications. The treatment is also targeted, meaning it focuses on a pathway closely tied to migraine rather than broadly affecting the whole nervous system.
Possible side effects
Common side effects include injection-site pain, redness, itching, swelling, or bruising. Some people report constipation, especially with erenumab. High blood pressure has also been reported in some patients using erenumab, so clinicians may monitor blood pressure more closely. Allergic reactions are uncommon but possible with any biologic treatment. Symptoms such as swelling of the face or throat, trouble breathing, hives, or severe dizziness require urgent medical attention.
Botox injections for chronic migraine
Botox, or onabotulinumtoxinA, is FDA-approved for preventing chronic migraine in adults. Chronic migraine is generally defined as headache on 15 or more days per month, with migraine features on at least eight of those days, for more than three months. In other words, chronic migraine is not “I had a rough Monday.” It is a neurological condition that can take over a person’s schedule, energy, work, family life, and sanity.
Botox for migraine is different from cosmetic Botox. The goal is not to look surprised at brunch. The medication is injected into a pattern of sites across the forehead, temples, back of the head, neck, and shoulders. A common protocol uses 31 small injections about every 12 weeks.
How Botox helps migraine
Botox appears to calm pain-processing nerves by reducing the release of chemicals involved in migraine signaling. It does not treat an attack that is already happening. Instead, it gradually lowers the frequency and severity of future attacks. Some people notice improvement after the first cycle, while others need two or three treatment cycles before deciding whether it is working.
Who may be a good candidate?
Botox is generally considered for adults with chronic migraine, not occasional migraine. It may be especially useful for people with frequent head and neck pain, predictable worsening between treatments, or poor tolerance of oral preventive medications. Insurance plans often require documentation of headache frequency and previous treatments, which is why a headache diary is more than a wellness influencer accessory. It can be the paperwork that helps unlock coverage.
Possible side effects of Botox
Common side effects include neck pain, soreness at injection sites, temporary muscle weakness, eyebrow or eyelid changes, and headache shortly after treatment. Rare but serious effects can occur if the toxin spreads beyond the injection area, causing trouble swallowing, speaking, or breathing. These complications are uncommon, but they are the reason Botox for migraine should be performed by trained clinicians who understand the approved migraine protocol.
Sumatriptan injection for fast migraine relief
Sumatriptan injection is an acute migraine treatment, not a preventive. It belongs to a class of medications called triptans. It is often used when attacks come on quickly, oral medications fail, or nausea and vomiting make tablets impractical. Some patients like having it as a rescue option because it can work faster than many oral treatments.
Sumatriptan helps by activating serotonin receptors, narrowing certain blood vessels, and reducing pain-signal transmission. That mechanism can be very effective, but it also means sumatriptan is not appropriate for everyone. People with certain heart conditions, stroke history, uncontrolled high blood pressure, or significant vascular disease may need other options.
Side effects may include tingling, flushing, warmth, dizziness, pressure sensations, injection-site reactions, or fatigue. Chest tightness can occur and should always be discussed with a clinician, especially if it is severe, unusual, or accompanied by shortness of breath.
Dihydroergotamine injection, or DHE
Dihydroergotamine is another acute migraine treatment. It may be given by injection or intravenously in medical settings, especially for severe or prolonged attacks. DHE acts on several serotonin receptors and can help interrupt stubborn migraine cycles. It is sometimes used in emergency departments, infusion centers, or specialist-supervised treatment plans.
DHE has important safety rules. It should not be combined too closely with triptans or certain other ergot medications. It is also not suitable for people with some cardiovascular conditions, uncontrolled hypertension, pregnancy, or certain medication interactions. Because of these restrictions, DHE should be used only under clear medical guidance.
Nerve blocks and trigger point injections
Some headache specialists use nerve blocks or trigger point injections as part of migraine care. These may involve injecting a local anesthetic, sometimes with another medication, near nerves such as the occipital nerves at the back of the head. The goal is to calm irritated pain pathways, particularly when neck pain, scalp tenderness, or occipital neuralgia-like symptoms overlap with migraine.
Nerve blocks are not the same as CGRP injections or Botox. Their effects may be shorter, and they are not always used as long-term standalone prevention. However, they can be helpful in selected patients, especially when migraine is tangled with nerve irritation, muscle tenderness, or a difficult attack pattern.
How doctors choose the right injectable migraine treatment
Choosing an injectable treatment is not a vending-machine decision. A clinician considers migraine frequency, attack severity, current medications, other medical conditions, pregnancy plans, insurance requirements, needle comfort, travel schedule, and whether the patient needs prevention, rescue therapy, or both.
Key questions that guide treatment
A doctor may ask: How many migraine days do you have each month? How many total headache days? Do attacks include aura? Do you vomit? Have you tried triptans? Do you use pain relievers more than a few days per week? Have oral preventives caused side effects? Do you have constipation, high blood pressure, heart disease, asthma, depression, or seizure history? The answers help narrow the safest and most practical choice.
For episodic migraine with several disabling days per month, a CGRP monoclonal antibody may be discussed. For chronic migraine, Botox, CGRP treatment, or sometimes a combination may be considered by specialists. For rapid rescue, sumatriptan injection may be appropriate if there are no cardiovascular concerns. For prolonged attacks, DHE may be used under supervision.
What to expect before, during, and after treatment
Before starting preventive injections, many clinicians recommend tracking headache days for at least a month. Write down attack dates, severity, symptoms, possible triggers, medication use, menstrual timing if relevant, sleep changes, and whether treatment helped. This record makes follow-up appointments more useful and less dependent on memory, which migraine loves to scramble.
For self-injected CGRP medications, the healthcare team should teach proper storage, injection technique, site rotation, and sharps disposal. Common injection sites include the abdomen, thigh, or upper arm, depending on the medication and whether a caregiver is helping. Let refrigerated medication warm to room temperature if the instructions allow it; cold injections can feel more dramatic than necessary.
For Botox, expect an office procedure that is usually quick. The injections are small and placed in a specific pattern. You may have mild soreness afterward. Most people return to normal activities the same day, although clinicians may give specific aftercare instructions.
For infusion therapy such as eptinezumab, expect an appointment at an infusion center or clinic. Staff will place an IV, administer the medication, and monitor for reactions. For DHE or other rescue infusions, monitoring may be more involved because nausea, blood pressure, and medication interactions matter.
How long do injectable migraine treatments take to work?
Acute injections such as sumatriptan are intended to work during the same migraine attack. Preventive treatments require more patience. Some patients notice improvement within the first month of CGRP therapy, while others need several months to judge the benefit. Botox often requires at least two treatment cycles before the full pattern becomes clear.
A fair trial usually means looking beyond one bad week. Migraine is influenced by hormones, weather shifts, sleep disruption, stress, illness, alcohol, skipped meals, and other chaos agents. A treatment may be helping even if it does not eliminate every attack. The practical goal is usually fewer migraine days, less disability, better function, and less reliance on rescue medication.
Safety tips and when to seek urgent care
Injectable migraine treatments are generally used safely when prescribed appropriately, but migraine patients should know red flags. Seek urgent medical care for a sudden “worst headache of life,” new weakness, confusion, fainting, fever with stiff neck, headache after head injury, new headache after age 50, vision loss, or symptoms that feel dramatically different from your usual migraine pattern.
Tell your clinician about all medications and supplements you use. This is especially important with triptans, DHE, antidepressants, blood pressure medicines, and other migraine drugs. Also discuss pregnancy, breastfeeding, planned surgery, allergies, constipation history, and cardiovascular risk factors. The safest migraine plan is the one that knows the whole story.
Practical experiences: what injectable migraine care can feel like
People often imagine injectable migraine treatment as a dramatic turning point: one shot, cue the music, migraines disappear forever, and everyone rides into the sunset wearing sunglasses because light no longer hurts. Real life is usually less cinematic but still meaningful. The experience often starts with frustration. A person may have tried over-the-counter pain relievers, prescription tablets, caffeine strategies, dark rooms, ice packs, magnesium, and the classic migraine prayer: “Please, not today.” By the time injectables enter the conversation, many patients are not looking for perfection. They are looking for fewer ruined days.
A common experience with CGRP self-injections is nervousness before the first dose. Even adults who handle work deadlines, taxes, and family group chats with bravery may hesitate in front of an autoinjector. The sound of the click can feel larger than life. After training, however, many people find the process manageable. The injection may sting briefly, the site may look red for a while, and then the day continues. The bigger emotional adjustment is waiting. Preventive treatment is not like flipping a light switch. It is more like dimming a migraine dashboard over time.
Some patients describe the first signs of improvement as subtle. They still get migraine attacks, but the attacks are shorter. Or they still need rescue medication, but it works better. Or they realize they made plans two weekends in a row without canceling. That kind of progress may not sound dramatic on paper, but to someone with migraine, it can feel like getting square footage back in their own life.
Botox experiences are different. The appointment involves many tiny injections, which sounds intimidating until people discover that each one is usually quick. The forehead, temples, scalp, neck, and shoulders may feel tender afterward. Some patients feel disappointed after the first round because the change is modest. Then, after the second or third cycle, they notice fewer headache days or less severe attacks. Others do not respond enough and move on to another strategy. That is not failure; it is data.
Acute injections create another kind of experience. A person who wakes up with a fast-moving migraine may use sumatriptan injection because waiting for a tablet feels impossible. The relief can be valuable, especially when vomiting is part of the attack. But acute injections also require discipline. Using rescue medication too often can backfire, so patients need a plan: when to inject, when to wait, when to call the doctor, and when to seek urgent care.
The most successful experiences usually involve partnership. Patients bring headache diaries, honest reports, and questions. Clinicians bring medical judgment, safety screening, and backup plans. Together, they adjust expectations. A win may be going from 18 migraine days a month to 9. It may be needing fewer sick days. It may be attending a child’s game, finishing a work project, or surviving a grocery store’s fluorescent lighting without feeling personally attacked by electricity.
Injectable migraine treatments are not for everyone, and they are not a cure. But for the right patient, they can be the difference between managing life around migraine and managing migraine around life. That difference matters.
Conclusion
Injectable treatments for migraine have changed the conversation from “try another pill and hope” to more targeted, flexible care. CGRP monoclonal antibodies can help prevent episodic or chronic migraine by blocking a key migraine pathway. Botox can reduce headache frequency in adults with chronic migraine. Sumatriptan and DHE injections can help stop certain attacks when oral medication is not enough or not practical. Nerve blocks may help selected patients with overlapping nerve irritation or difficult headache patterns.
The best treatment depends on your migraine pattern, medical history, safety risks, treatment goals, and access. A headache diary, an honest discussion with a clinician, and realistic expectations can make injectable therapy far more effective. Migraine may be stubborn, but modern treatment is no longer stuck in the dark agesor the dark room.